Article Information
History
- April 12, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gabriella Liszkay1,*,
- Angela Benedek2,*,
- Csaba Polgár1,
- Judit Oláh4,
- Péter Holló5,
- Gabriella Emri6,
- András Csejtei7,
- István Kenessey1,
- Zoltán Polányi2,
- Kata Knollmajer2,
- Máté Várnai2,3,
- Zoltán Vokó3,
- Balázs Nagy3,
- György Rokszin8,
- Ibolya Fábián8,9,
- Zsófia Barcza10,
- Rolland Gyulai11,** and
- Zoltan Kiss2,**,†
- 1National Institute of Oncology, Budapest, Hungary
- 2MSD Pharma Hungary Ltd., Budapest, Hungary
- 3Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary
- 4Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary
- 5Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary
- 6Department of Dermatology, University of Debrecen, Debrecen, Hungary
- 7Department of Oncoradiology, Markusovszky University Teaching Hospital, Szombathely, Hungary
- 8RxTarget Ltd., Szolnok, Hungary
- 9University of Veterinary Medicine, Budapest, Hungary
- 10Syntesia Medical Communications Ltd., Budapest, Hungary
- 11Department of Dermatology, Venereology and Oncodermatology, Faculty of Medicine, University of Pécs, Pécs, Hungary
- ↵†Corresponding author
: Zoltán Kiss MD, MSD Pharma Hungary Ltd., 1095 Lechner O fs 8. Budapest, Hungary, zoltan_kiss2{at}merck.com, +36-30-681-7524
Posted April 12, 2022.
SIGNIFICANT IMPROVEMENT IN MELANOMA SURVIVAL OVER THE LAST DECADE: A HUNGARIAN NATIONWIDE STUDY BETWEEN 2011–2019
